Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ATOSSA THERAPEUTICS, INC. | Former EVP, CFO, & Director, Director | Common Stock | 55 | $35.80 | $0.65 | Nov 15, 2023 | Direct |
ATOSSA THERAPEUTICS, INC. | Former EVP, CFO, & Director, Director | Stock Option (right to buy) | 2.6M | Jun 1, 2023 | Direct | ||
ATAI Life Sciences N.V. | Chief Financial Officer | Stock Option | 228K | Mar 2, 2022 | Direct | ||
Altimmune, Inc. | Chief Financial Officer | Stock Options (option to buy) | 225K | Nov 11, 2024 | Direct | ||
Altimmune, Inc. | Chief Financial Officer | Restricted Stock Units | 75K | Nov 11, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ALT | Altimmune, Inc. | Nov 11, 2024 | 2 | $0 | 4 | Nov 12, 2024 | Chief Financial Officer |
ALT | Altimmune, Inc. | Nov 11, 2024 | 0 | $0 | 3 | Nov 12, 2024 | Chief Financial Officer |
ATOS | ATOSSA THERAPEUTICS, INC. | Nov 15, 2023 | 1 | -$32.5K | 4 | Nov 17, 2023 | Former EVP, CFO, & Director, Director |
ATOS | ATOSSA THERAPEUTICS, INC. | Jun 20, 2023 | 1 | $48.5K | 4 | Jun 20, 2023 | EVP & CFO, Director |
ATOS | ATOSSA THERAPEUTICS, INC. | Jun 1, 2023 | 1 | $0 | 4 | Jun 5, 2023 | EVP & CFO, Director |
ATOS | ATOSSA THERAPEUTICS, INC. | May 4, 2023 | 1 | $0 | 4 | May 5, 2023 | Director |
ATOS | ATOSSA THERAPEUTICS, INC. | May 13, 2022 | 1 | $0 | 4 | May 16, 2022 | Director |
ATAI | ATAI Life Sciences N.V. | Mar 2, 2022 | 1 | $0 | 4 | Mar 4, 2022 | Chief Financial Officer |
ATOS | ATOSSA THERAPEUTICS, INC. | Jul 2, 2021 | 10 | -$600K | 4 | Jul 7, 2021 | Director |
ATAI | ATAI Life Sciences N.V. | Jun 22, 2021 | 1 | $70K | 4 | Jun 24, 2021 | Chief Financial Officer |
ATAI | ATAI Life Sciences N.V. | Jun 17, 2021 | 1 | $0 | 4 | Jun 22, 2021 | Chief Financial Officer |
ATAI | ATAI Life Sciences B.V. | Jun 17, 2021 | 0 | $0 | 3 | Jun 17, 2021 | Chief Financial Officer |
ATOS | ATOSSA THERAPEUTICS, INC. | May 14, 2021 | 1 | $0 | 4 | May 18, 2021 | Director |